These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7881986)

  • 1. Monitoring of iron status and iron supplementation in patients treated with erythropoietin.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):620-5. PubMed ID: 7881986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron requirements in erythropoietin therapy.
    Eschbach JW
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron monitoring and supplementation: how do we achieve the best results?
    Schaefer RM; Schaefer L
    Nephrol Dial Transplant; 1998; 13 Suppl 2():9-12. PubMed ID: 9566484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biochemical and hematological assessment of iron metabolism].
    Nathanson S; Deschênes G; Bensman A
    Arch Pediatr; 1999 Nov; 6(11):1199-204. PubMed ID: 10587746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.
    Caravaca F; Vagace JM; Aparicio A; Groiss J; Pizarro JL; Alonso N; Garcia MC; Arrobas M; Cubero J; Esparrago J
    Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
    Tarng DC; Huang TP; Chen TW; Yang WC
    Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM; Bahner U
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron status markers and serum erythropoietin in 120 mothers and newborn infants. Effect of iron supplementation in normal pregnancy.
    Milman N; Agger AO; Nielsen OJ
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):200-4. PubMed ID: 8122498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia.
    Baumann Kurer S; Seifert B; Michel B; Ruegg R; Fehr J
    Br J Haematol; 1995 Dec; 91(4):820-6. PubMed ID: 8547124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
    Chang J; Bird R; Clague A; Carter A
    Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Bahrainwala J; Berns JS
    Semin Nephrol; 2016 Mar; 36(2):94-8. PubMed ID: 27236129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy.
    Bhandari S; Norfolk D; Brownjohn A; Turney J
    Am J Kidney Dis; 1997 Dec; 30(6):814-21. PubMed ID: 9398126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
    Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.
    Thomas C; Kirschbaum A; Boehm D; Thomas L
    Med Oncol; 2006; 23(1):23-36. PubMed ID: 16645227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
    Fishbane S; Frei GL; Maesaka J
    Am J Kidney Dis; 1995 Jul; 26(1):41-6. PubMed ID: 7611266
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.